6-K/A

AMENDMENT NO. 1 TO FORM 6-K

Company: Tiziana Life Sciences Ltd
Filed: February 22, 2022
Period of Report: February 22, 2022
Accession Number: 0001213900-22-008593

View Document ↗ View on SEC.gov ↗